Health ❯ Vaccines

Flu Vaccine

Public Health FluMist Recommendations Moderna FDA Approval FDA Advisory Panel Effectiveness Over Time Vaccine Hesitancy AstraZeneca Effectiveness mRNA Vaccines mRNA Technology Nasal Spray

FDA Reverses Course To Review Moderna’s mRNA Flu Shot Under Split Pathway

The reversal follows a rare refusal-to-file over the trial comparator for seniors, with a decision due August 5.

AstraZeneca Launches FluMist Home Direct-to-Consumer Nasal Vaccine in 34 States